<SEC-DOCUMENT>0000921895-19-003037-index.html : 20191219
<SEC-HEADER>0000921895-19-003037.hdr.sgml : 20191219
<ACCEPTANCE-DATETIME>20191219171532
ACCESSION NUMBER:		0000921895-19-003037
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20191219
DATE AS OF CHANGE:		20191219

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aclaris Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001557746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				460571712
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89137
		FILM NUMBER:		191296672

	BUSINESS ADDRESS:	
		STREET 1:		640 LEE ROAD
		STREET 2:		SUITE 200
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087
		BUSINESS PHONE:		484-324-7933

	MAIL ADDRESS:	
		STREET 1:		640 LEE ROAD
		STREET 2:		SUITE 200
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arkin Moshe
		CENTRAL INDEX KEY:			0001321178

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	MAIL ADDRESS:	
		STREET 1:		6 HACHOSHLIM ST.
		CITY:			HERZELIA
		STATE:			L3
		ZIP:			4672406
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>sc13da212466002_12192019.htm
<DESCRIPTION>AMENDMENT NO. 2 TO THE SCHEDULE 13D
<TEXT>
Document 1 - file: sc13da212466002_12192019.htm

</DOCUMENT>
</SEC-DOCUMENT>